Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Design and synthesis of spiro-linked azacycloalkane–dihydropyrano[4,3-d]pyrimidine compounds. / Zhuravlev, Maxim E.; Komarova, Kristina Yuryevna; Khudiakova, Lyubov V; Chudinov, Mikhail Vasil'evich; Lukin, Alexei Yur'evich; Dar’in, Dmitry Viktorovich.
в: Mendeleev Communications, Том 36, № 4, 2026.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Design and synthesis of spiro-linked azacycloalkane–dihydropyrano[4,3-d]pyrimidine compounds
AU - Zhuravlev, Maxim E.
AU - Komarova, Kristina Yuryevna
AU - Khudiakova, Lyubov V
AU - Chudinov, Mikhail Vasil'evich
AU - Lukin, Alexei Yur'evich
AU - Dar’in, Dmitry Viktorovich
PY - 2026
Y1 - 2026
N2 - The aim of this work was to synthesize azaspirocyclic derivatives of dihydropyrano[4,3-d]pyrimidine containing aliphatic or aromatic substituents at the second position of the pyrimidine ring. The synthesis was carried out starting from commercially available protected azacyclic ketones by Prins spirocyclization followed by regiospecific condensation with dimethylformamide dimethyl acetal and various amidines. The resulting compound series is characterized by high chemical diversity among the peripheral fragments. The new scaffold appears to be a valuable building block for drug development. The new core advantages were tested in the synthesis of several model compounds with antitubercular potential.
AB - The aim of this work was to synthesize azaspirocyclic derivatives of dihydropyrano[4,3-d]pyrimidine containing aliphatic or aromatic substituents at the second position of the pyrimidine ring. The synthesis was carried out starting from commercially available protected azacyclic ketones by Prins spirocyclization followed by regiospecific condensation with dimethylformamide dimethyl acetal and various amidines. The resulting compound series is characterized by high chemical diversity among the peripheral fragments. The new scaffold appears to be a valuable building block for drug development. The new core advantages were tested in the synthesis of several model compounds with antitubercular potential.
U2 - 10.71267/mencom.7965
DO - 10.71267/mencom.7965
M3 - Article
VL - 36
JO - Mendeleev Communications
JF - Mendeleev Communications
SN - 0959-9436
IS - 4
ER -
ID: 151907435